Preview

Safety and Risk of Pharmacotherapy

Advanced search

THE SAFETY ASSESSMENT OF MEDICINAL PLANTS

Abstract

The problems of safety evaluation of medicinal plants formulations in the Russian Federation, Europe and USA are presented. Safety issues of medicinal plants, as well as the adverse reactions of some herbal medicines are discussed. The main groups of exogenous (toxic metals, pesticides) and endogenous toxic substances of medicinal plants are represented. The maximum allowable concentrations of endogenous toxic substances (pyrrolizidine alkaloids, glycolic acid, azaron and other) most often defined in medicinal plants are given. The authors substantiate the necessity of tightening of the requirements for normative documents, which ensure the safety of medicinal plants.

About the Authors

E. V. Shikh
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian Federation
Russian Federation


V. M. Bulayev
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian Federation
Russian Federation


O. A. Demidova
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», Ministry of Health of the Russian Federation
Russian Federation


References

1. Яковлев Г.П. Лекарственные растения. БРЭ, т. 17, с. 193-196.

2. The complete German commission E monographs. Therapeutic guide to herbal medicines. 1998, p. 17; р. 21.

3. Herbal Medicine. Expanded commission E monographs. 2000, p.475-477.

4. Kennedy J. Herbal and supplement use in the US adult population. Clinical Therap., 2005, v. 27, p. 1847-1858

5. Holder S. Regulatory aspects of herbal medicine: a global view. Regulatory Review., 2001, v. 4, p. 13-17.

6. Quality control of medicinal plant materials. WHO, 1998.

7. Regulatory situation of herbal medicines-a worldwide review WHO, 1998, p. 1-45.

8. Самылина И.А., Булаев В.М. Проблемы безопасности лекарственных растений, содержащих эндогенные токсичные вещества. Фармация, 2009, № 3, с.6-8.

9. Тутельян В.А., Белоусов Ю.Б., Гуревич К.Г. Безопасность и эффективность биологически активных веществ растительного происхождения. 2007.

10. Булаев В.М., Ших Е.В., Сычев Д.А. Безопасность и эффективность лекарственных растений. 2013.

11. Barnes J., Anderson L., Phillipson J. Herbal medicines, 2002, 2 ed.

12. Roder E. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie, 1995, v. 50, p. 83-98.

13. European Scientific Cooperative on Phytotherapy (ESCOP) monographs. 2003.

14. Physicians Desk Reference (PDR) for Herbal Medicines, 2004.

15. Рыженко В.И. Сборы лекарственных растений, 2007.

16. Lake B. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessement. Food. Chem. Toxicol., 1999, v. 37, p. 423-452


Review

For citations:


Shikh E.V., Bulayev V.M., Demidova O.A. THE SAFETY ASSESSMENT OF MEDICINAL PLANTS. Safety and Risk of Pharmacotherapy. 2015;(2):23-29. (In Russ.)

Views: 1348


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)